For the year ending 2025-12-31, OGN made $6,216M in revenue. $187M in net income. Net profit margin of 3.01%.
| Income Statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenues | 6,216 | 6,403 | 6,263 | 6,174 |
| Cost of sales | 2,903 | 2,688 | 2,515 | 2,294 |
| Gross profit | 3,313 | 3,715 | - | - |
| Selling, general and administrative | 1,721 | 1,760 | 1,893 | 1,704 |
| Research and development | 366 | 469 | 528 | 471 |
| Acquired in-process research and development and milestones | 6 | 81 | 8 | 107 |
| Goodwill impairment | 301 | - | - | - |
| Restructuring costs | 95 | 31 | 62 | 28 |
| Interest expense | 504 | 520 | 527 | 422 |
| Exchange losses | -14 | -26 | -42 | -11 |
| Other (income) expense, net | 119 | -21 | -15 | -15 |
| Total, costs expenses and other | - | - | 5,590 | 5,052 |
| Income before income taxes | 425 | 807 | 673 | 1,122 |
| Income tax expense (benefit) | 238 | -57 | -350 | 205 |
| Net income from continuing operations | - | - | 1,023 | 917 |
| Loss from discontinued operations - net of tax | - | - | 0 | 0 |
| Net income | 187 | 864 | 1,023 | 917 |
| Basic EPS | 0.72 | 3.36 | 4.01 | 3.61 |
| Diluted EPS | 0.72 | 3.33 | 3.99 | 3.59 |
| Basic Average Shares | 259,495,000 | 257,046,000 | 255,239,000 | 254,082,000 |
| Diluted Average Shares | 260,764,000 | 259,152,000 | 256,270,000 | 255,169,000 |
Organon & Co. (OGN)
Organon & Co. (OGN)